4/26
04:14 pm
abbv
Why AbbVie Stock Stumbled Today Despite the Earnings Beat [Yahoo! Finance]
Low
Report
Why AbbVie Stock Stumbled Today Despite the Earnings Beat [Yahoo! Finance]
4/26
02:00 pm
abbv
AbbVie (ABBV) Beats on Q1 Earnings & Sales, Ups '24 EPS View [Yahoo! Finance]
Low
Report
AbbVie (ABBV) Beats on Q1 Earnings & Sales, Ups '24 EPS View [Yahoo! Finance]
4/26
12:26 pm
abbv
AbbVie's Q1: Positive Surprise [Seeking Alpha]
Low
Report
AbbVie's Q1: Positive Surprise [Seeking Alpha]
4/26
11:59 am
abbv
AbbVie (ABBV) Reports Q1 Earnings: What Key Metrics Have to Say [Yahoo! Finance]
Low
Report
AbbVie (ABBV) Reports Q1 Earnings: What Key Metrics Have to Say [Yahoo! Finance]
4/26
11:28 am
abbv
AbbVie Q1 report beats Street despite plunging Humira sales [Seeking Alpha]
Low
Report
AbbVie Q1 report beats Street despite plunging Humira sales [Seeking Alpha]
4/26
08:05 am
abbv
Achieving the right balance of work and life [Globe and Mail, The (Toronto, Canada)]
Medium
Report
Achieving the right balance of work and life [Globe and Mail, The (Toronto, Canada)]
4/26
08:05 am
abbv
Fostering wellness and growth to create the Best Workplaces [Globe and Mail, The (Toronto, Canada)]
Medium
Report
Fostering wellness and growth to create the Best Workplaces [Globe and Mail, The (Toronto, Canada)]
4/26
07:42 am
abbv
AbbVie Reports First-Quarter 2024 Financial Results [Yahoo! Finance]
Medium
Report
AbbVie Reports First-Quarter 2024 Financial Results [Yahoo! Finance]
4/26
07:35 am
abbv
AbbVie Reports First-Quarter 2024 Financial Results
Medium
Report
AbbVie Reports First-Quarter 2024 Financial Results
4/25
04:44 pm
abbv
Evernorth announces Humira biosimilar available at $0 out of pocket for Accredo patients in June [Yahoo! Finance]
Medium
Report
Evernorth announces Humira biosimilar available at $0 out of pocket for Accredo patients in June [Yahoo! Finance]
4/25
08:10 am
abbv
New Data Show RINVOQ® (upadacitinib) Demonstrated Superiority Versus DUPIXENT® (dupilumab) Across Primary and All Secondary Endpoints in an Open-Label Head-to-Head Atopic Dermatitis Study [Yahoo! Finance]
Low
Report
New Data Show RINVOQ® (upadacitinib) Demonstrated Superiority Versus DUPIXENT® (dupilumab) Across Primary and All Secondary Endpoints in an Open-Label Head-to-Head Atopic Dermatitis Study [Yahoo! Finance]
4/25
08:00 am
abbv
New Data Show RINVOQ® (upadacitinib) Demonstrated Superiority Versus DUPIXENT® (dupilumab) Across Primary and All Secondary Endpoints in an Open-Label Head-to-Head Atopic Dermatitis Study
Low
Report
New Data Show RINVOQ® (upadacitinib) Demonstrated Superiority Versus DUPIXENT® (dupilumab) Across Primary and All Secondary Endpoints in an Open-Label Head-to-Head Atopic Dermatitis Study
4/25
04:19 am
abbv
Global Transplant Market Forecast Report 2024-2029: Investment by Major Players like Abbvie and Arthrex in Organ Transplantation is Fueling Market Growth [Yahoo! Finance]
Low
Report
Global Transplant Market Forecast Report 2024-2029: Investment by Major Players like Abbvie and Arthrex in Organ Transplantation is Fueling Market Growth [Yahoo! Finance]
4/24
08:53 am
abbv
Glaucoma Global Clinical Trials Review 2024: Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End Points Status [Yahoo! Finance]
Low
Report
Glaucoma Global Clinical Trials Review 2024: Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End Points Status [Yahoo! Finance]
4/23
11:08 am
abbv
Gear Up for AbbVie (ABBV) Q1 Earnings: Wall Street Estimates for Key Metrics [Yahoo! Finance]
Low
Report
Gear Up for AbbVie (ABBV) Q1 Earnings: Wall Street Estimates for Key Metrics [Yahoo! Finance]
4/23
08:12 am
abbv
Allergan Aesthetics Invites Consumers to Be the Face of BOTOX® Cosmetic (onabotulinumtoxinA) and Their Other Biggest Brands [Yahoo! Finance]
Low
Report
Allergan Aesthetics Invites Consumers to Be the Face of BOTOX® Cosmetic (onabotulinumtoxinA) and Their Other Biggest Brands [Yahoo! Finance]
4/23
08:00 am
abbv
Allergan Aesthetics Invites Consumers to Be the Face of BOTOX® Cosmetic (onabotulinumtoxinA) and Their Other Biggest Brands
Low
Report
Allergan Aesthetics Invites Consumers to Be the Face of BOTOX® Cosmetic (onabotulinumtoxinA) and Their Other Biggest Brands
4/22
02:53 pm
abbv
AbbVie (ABBV) to Report Q1 Earnings: What's in the Cards? [Yahoo! Finance]
Low
Report
AbbVie (ABBV) to Report Q1 Earnings: What's in the Cards? [Yahoo! Finance]
4/22
10:56 am
abbv
Improve Your Retirement Income with These 3 Top-Ranked Dividend Stocks [Yahoo! Finance]
Low
Report
Improve Your Retirement Income with These 3 Top-Ranked Dividend Stocks [Yahoo! Finance]
4/22
09:54 am
abbv
Buying the Dip in These 3 Undervalued Dividend Stocks [Yahoo! Finance]
Low
Report
Buying the Dip in These 3 Undervalued Dividend Stocks [Yahoo! Finance]
4/19
12:14 pm
abbv
Earnings Preview: AbbVie (ABBV) Q1 Earnings Expected to Decline [Yahoo! Finance]
Low
Report
Earnings Preview: AbbVie (ABBV) Q1 Earnings Expected to Decline [Yahoo! Finance]
4/18
09:11 am
abbv
Phase 3 SELECT-GCA Study of Upadacitinib (RINVOQ®) Showed Positive Results in Patients With Giant Cell Arteritis [Yahoo! Finance]
Low
Report
Phase 3 SELECT-GCA Study of Upadacitinib (RINVOQ®) Showed Positive Results in Patients With Giant Cell Arteritis [Yahoo! Finance]
4/18
08:31 am
abbv
Phase 3 SELECT-GCA Study of Upadacitinib (RINVOQ®) Showed Positive Results in Patients With Giant Cell Arteritis
Low
Report
Phase 3 SELECT-GCA Study of Upadacitinib (RINVOQ®) Showed Positive Results in Patients With Giant Cell Arteritis
4/18
06:54 am
abbv
Big Growth Ahead: Biologic Drugs Market to Hit $823.4 Billion by 2028, Reveals BCC Research [Yahoo! Finance]
Low
Report
Big Growth Ahead: Biologic Drugs Market to Hit $823.4 Billion by 2028, Reveals BCC Research [Yahoo! Finance]
4/17
07:39 pm
abbv
AbbVie (ABBV) Increases Despite Market Slip: Here's What You Need to Know [Yahoo! Finance]
Low
Report
AbbVie (ABBV) Increases Despite Market Slip: Here's What You Need to Know [Yahoo! Finance]